top of page
HOME
HOME

Why You're Here

WE MAXIMISE THE VALUE OF MEDICINES
ValueBase is driven by a singular mission: to ensure all patients have timely access to the best treatments available, no matter where they live.

We partner with pharma companies to visualise the access environment and highlight disparities in target therapy areas. Our AI-powered data solutions provide a unique evidence-base to inform strategies that maximise the value of medicines. 

The world’s biggest pharma companies use ValueBase as their data insights partner – helping them design agile access strategies that support every stage of the product lifecycle, from early asset to loss of exclusivity.

Together we’re unlocking equitable access to medicines. 
depositphotos_40759589-stock-photo-natural-female-eye.webp
We specialise in AI-powered data solutions that help pharma companies identify and manage barriers to access – allowing them to design strategies based on real-world indicators and meaningful analogues. We also partner with health providers and policymakers to highlight gaps in access that need addressing.

Our descriptive and predictive AI-led solutions can track the access environment in five key European markets – France, Germany, Italy, Spain and the UK – mapping the changes driving regional access in each country, across formularies, guidelines or contracts. Insights can be combined with your latest prescribing data to give you critical insights around availability and impact.

We can also help you see into the future. Our AI solutions – powered by the highest quality longitudinal data out there – enable next generation predictive modelling, allowing companies to pre-empt (and plan for) negative access events with confidence. Now you really can predict the predictable and see the unseeable.
SEE THE UNSEEABLE

How We Help

Anchor 2
bottom of page